Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
A20010081	卡贝缩宫素	carbetocin	Active ingredient	Chemical Drugs	New Drug Application	2001-10-29	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated	2003-03-19	view
J0301575	卡贝缩宫素注射液	carbetocin	Injection	Chemical Drugs	Supplementary Application	2004-06-29	香港辉凌制药有限公司北京代表处	Certificate Issued	2004-11-12	view
H20010088	去氨加压素	desmopressin	Active ingredient	Chemical Drugs	Import Drug Application	2001-04-27	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated		view
B20020117	注射用曲普瑞林控释剂	triptorelin	Lyophilized	Chemical Drugs	Import Drug Application	2002-09-25	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated	2003-05-19	view
H20010085	注射用特利加压素	terlipressin	Lyophilized	Chemical Drugs	Import Drug Application	2001-04-27	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated		view
A20010084	注射用高纯度尿促性素	menotrophin	Lyophilized	Chemical Drugs	New Drug Application	2001-11-07	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated	2003-11-13	view
H20020278	特利加压素注射液	terlipressin	Injection	Chemical Drugs	Import Drug Application	2003-08-13	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated		view
H20020287	美沙拉秦栓剂	mesalazine	Suppository	Chemical Drugs	Import Drug Application	2002-12-04	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated	2003-07-08	view
H20020288	美沙拉秦缓释片	mesalazine	Tablet, extended release	Chemical Drugs	Import Drug Application	2002-12-04	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated	2003-07-24	view
B20020023	美沙拉秦缓释片	mesalazine	Tablet, extended release	Chemical Drugs	Import Drug Application	2002-04-22	香港辉凌制药有限公司北京代表处	Pending Approval	2003-07-07	view
A20010006	阿托西班	atosiban	Active ingredient	Chemical Drugs	New Drug Application	2001-04-27	香港辉凌制药有限公司北京代表处	Approval Completed-Pending Certificated	2002-08-07	view